Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings
Enacted
Email me when HJR 162 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HJR 162. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Enacted
Summary
The resolution asks the Alabama Medicaid Agency to examine how covering GLP‑1 medications for weight management could affect program costs and potential savings, and to share its findings with the Legislature before the 2027 session. It focuses on roughly 110,000 adult and child Medicaid members who might qualify for these drugs. The aim is to inform future coverage decisions amid high obesity‑related health expenses.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HJR 162
3 free questions a day, no accountHistory
- Enacted
- Reported from RULES (RULES)
- Ready to Enroll
- Enrolled
- Delivered to Governor
- Reported Out of Committee Second House
- Reported Out of Committee House of Origin
- Reported from Rules (Rules)
- Received in the Senate and referred to the Senate committee on RULES
- Pending Committee Action in Second House (RULES)
- Lovvorn motion to Adopt - Adopted Voice Vote
- Received in the House and referred to the House committee on Rules
The 12 most recent of 13 recorded actions.
Sponsors
- Ed Oliver (R) · sponsor
- Oliver
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HJR 162 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HJR 162 freeOr ask your AI assistant about HJR 162 directly:
Add to Claude, ChatGPT or Cursor